These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34691029)

  • 1. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
    Subtil B; Cambi A; Tauriello DVF; de Vries IJM
    Front Immunol; 2021; 12():724883. PubMed ID: 34691029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
    Subtil B; Iyer KK; Poel D; Bakkerus L; Gorris MAJ; Escalona JC; van den Dries K; Cambi A; Verheul HMW; de Vries IJM; Tauriello DVF
    Front Immunol; 2023; 14():1105244. PubMed ID: 36761758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids model.
    Subtil B; van der Hoorn IAE; Cuenca-Escalona J; Becker AMD; Alvarez-Begue M; Iyer KK; Janssen J; van Oorschot T; Poel D; Gorris MAJ; van den Dries K; Cambi A; Tauriello DVF; de Vries IJM
    Eur J Immunol; 2024 Jun; 54(6):e2350891. PubMed ID: 38509863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
    Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
    Front Immunol; 2020; 11():614300. PubMed ID: 33643296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
    Kamal Y; Schmit SL; Frost HR; Amos CI
    Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Ga├čler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.
    O'Toole A; Michielsen AJ; Nolan B; Tosetto M; Sheahan K; Mulcahy HE; Winter DC; Hyland JM; O'Connell PR; Fennelly D; O'Donoghue D; O'Sullivan J; Doherty GA; Ryan EJ
    Br J Cancer; 2014 Aug; 111(5):927-32. PubMed ID: 25058349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell defects in the colorectal cancer.
    Legitimo A; Consolini R; Failli A; Orsini G; Spisni R
    Hum Vaccin Immunother; 2014; 10(11):3224-35. PubMed ID: 25483675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
    Guo L; Wang C; Qiu X; Pu X; Chang P
    Front Immunol; 2020; 11():1052. PubMed ID: 32547556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
    Fu C; Jiang A
    Front Immunol; 2018; 9():3059. PubMed ID: 30619378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
    Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
    BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
    Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
    Front Immunol; 2021; 12():667177. PubMed ID: 34025668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer.
    Xiong Y; Wang Y; Tiruthani K
    Nanomedicine; 2019 Oct; 21():102034. PubMed ID: 31207314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
    Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
    Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice.
    Xu F; Ye YJ; Liu W; Kong M; He Y; Wang S
    Scand J Gastroenterol; 2010 Jun; 45(6):707-13. PubMed ID: 20205622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal multicellular organoids to study colorectal cancer.
    Idris M; Alves MM; Hofstra RMW; Mahe MM; Melotte V
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188586. PubMed ID: 34216725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the intratumoral microbiota in colorectal cancer immunotherapy.
    Fan S; Zhang W; Zhou L; Wang D; Tang D
    Int Immunopharmacol; 2024 Aug; 137():112537. PubMed ID: 38909493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.